Evidence map›Paper›PMID 21116437›Full record

ArticleACS medicinal chemistry letters2010

Concise syntheses of the abyssinones and discovery of new inhibitors of prostate cancer and MMP-2 expression.

Rebecca L Farmer, Margaret M Biddle, Antoinette E Nibbs, Xiaoke Huang, Raymond C Bergan, Karl A Scheidt

Open access · greenAbstract read
In one paragraph

Article in ACS medicinal chemistry letters, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
5.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Rebecca L FarmerDepartment of Chemistry, Center for Molecular Innovation and Drug Discovery, Chemistry of Life Processes Institute, Northwestern University, Silverman Hall, Evanston, Illinois 60208.
Margaret M Biddle
Antoinette E Nibbs
Xiaoke Huang
Raymond C Bergan
Karl A Scheidt
Northwestern University · USRobert H. Lurie Comprehensive Cancer Center of Northwestern University

Funding

DRUG DISCOVERY TRAINING IN AGE-RELATED DISORDERST32AG000260 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI WATTERSON, DANIEL MARTIN · 1998 to 2010
$2.7M
Synthesis of Anticancer Pyran Natural ProductsR01CA126827 · NCI · NORTHWESTERN UNIVERSITY · PI SCHEIDT, KARL A · 2009 to 2010
$551k
Synthesis and Evaluation of Anti-Tumor FlavanoidsF31CA132617 · NCI · NORTHWESTERN UNIVERSITY · PI NIBBS, ANTOINETTE EVADNEY · 2008 to 2011
$145k
Molecular Inhibitors of Prostate Cancer MetastasisF31CA138097 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI FARMER, REBECCA LEIGH · 2008 to 2011
$111k
NCI NIH HHS F31 CA132617NCI NIH HHS F31 CA138097NCI NIH HHS R01 CA126827NIA NIH HHS T32 AG000260
6 · The paper itself

Abstract

Hydrogen-bonding catalysis is an emerging field that facilitates rapid access to medicinally relevant enantioenriched small molecules. Here, we report the first asymmetric total syntheses of four members of the abyssinone class of natural products (I, II, III, and IV 4´-OMe) via quinine- or quinidine-derived thiourea-catalyzed intramolecular conjugate additions of β-keto ester alkylidenes. This concise strategy includes a tandem deprotection/decarboxylation final step that delivers all four natural products and their corresponding antipodes. A preliminary evaluation of all of these small molecules against a metastatic human prostate cancer cell line has identified that these compounds selectively and differentially inhibit cell growth and downregulate the expression of matrix metalloproteinase-2 (MMP-2) at non-toxic concentrations.

Identifiers

PMID21116437
PMCPMC2992379
OpenAlexW1965999026

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.